China approves J&J psoriasis pill Icotyde, says drugmaker
- Posted on August 28, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
China approves J&J psoriasis pill Icotyde, says drugmaker
(This Aug 27 story has been republished, with no changes to text.) SHANGHAI, Aug 27 (Reuters) - China's drug regulator has approved Johnson & Johnson's oral pill for psoriasis, the company said on Thursday, intensifying competition in the world's second-largest pharmaceutical market with rivals including Bristol Myers Squibb and AbbVie. Psoriasis, a chronic autoimmune condition that causes
